期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
The tumor immunosuppressive microenvironment impairs the therapy of anti-HER2/neu antibody 被引量:2
1
作者 Meng Xu Xuexiang Du +4 位作者 Mingyue liu Sirui li xiaozhu li Yang-Xin Fu Shengdian Wang 《Protein & Cell》 SCIE CSCD 2012年第6期441-449,共9页
It has been well established that immune surveillance plays critical roles in preventing the occurrence and prog-ression of tumor.More and more evidence in recent years showed the host anti-tumor immune responses also... It has been well established that immune surveillance plays critical roles in preventing the occurrence and prog-ression of tumor.More and more evidence in recent years showed the host anti-tumor immune responses also play important roles in the chemotherapy and radiotherapy of cancers.Our previous study found that tumor-targeting therapy of anti-HER2/neu mAb is mediated by CD8+T cell responses.However,we found here that enhancement of CD8+T cell responses by combination therapy with IL-15R/IL-15 fusion protein or anti-CD40,which are strong stimultors for T cell responses,failed to promote the tumor therapeutic effects of anti-HER2/neu mAb.Analysis of tumor microenviornment showed that tumor tissues were heavily infiltrated with the immunosuppressive macrophages and most tumor infiltrating T cells,especially CD8^(+)T cells,expressed high level of inhibitory co-signaling receptor PD-1.These data suggest that tumor microenvironment is dominated by the immunosuppressive strategies,which thwart anti-tumor immune responses.Therefore,the successful tumor therapy should be the removal of inhibitory signals in the tumor microenvir-onment in combination with other therapeutic strategies. 展开更多
关键词 anti-HER2/neu antibody CD8^(+)T cells tu-mor microenvironment tumor therapy immune suppression
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部